openPR Logo
Press release

A Deep tech startup is disrupting dairy industry in Chennai Demo Day at IIT-Madras Research Park.

02-18-2019 01:24 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Ariviya Inc.

A Deep tech startup Ariviya is disrupting dairy industry in Chennai Demo Day at IIT-Madras Research Park.

A Deep tech startup Ariviya is disrupting dairy industry in Chennai Demo Day at IIT-Madras Research Park.

Summary:
A Deep tech startup Ariviya is disrupting dairy industry in Chennai Demo Day at IIT-Madras Research Park. Ariviya using Nanobiotechnology invented "MammaryO" to prevent "Mastitis" which is considered as the costliest disease in the dairy industry for a milking cow.

Full Article:
A Deep tech startup Ariviya is disrupting dairy industry in Chennai Demo Day at IIT-Madras Research Park. Ariviya using Nanobiotechnology invented "MammaryO" to prevent "Mastitis" which is considered as the costliest disease in the dairy industry for a milking cow.

Full Article:
A Deep tech startup Ariviya is disrupting dairy industry in Chennai Demo Day at IIT-Madras Research Park. Ariviya using Nanobiotechnology invented "MammaryO" to prevent "Mastitis" which is considered as the costliest disease in the dairy industry for a milking cow.

IIT Madras Incubation Cell and TiE-Chennai hosted the first 'Chennai Demo Day' at IIT-Madras Research Park with an objective to showcase India's leading deep-technology startups and help them to interact with investors, industry, government, and institutions across India. 200+ startups demonstrated their Deep Tech innovations including Ariviya.

"Our Vision is to help dairy farmers to Increase milk quality and milk production by preventing diseases that affect the quality and quantity of the milk. We use Deep Tech approach to achieve that vision. Typically in a Deep Tech industry, the technologists and scientists, work together to solve a problem in an unconventional way. In Ariviya that's what we do, we are a team of Nanotechnology scientist, Biotechnology scientist, Dairy Farm Veterinarian, Informational Technologist, Dairy Farmer and we are working together to protect dairy cow udder and hoof from bacterial infections." said, Swami Nathan, CEO, and Founder of Ariviya Inc.

"Bovine Mastitis is a bacterial infection that comes in a dairy cow in mammary gland udder area, mainly in the teat, usually caused by contact with milking equipment, bedding, and unhygienic farm environment," said Dr.Chinnadurai, a senior Veterinarian who has several years of experience in consulting Indian and International Dairy Farms.

Bovine mastitis is the costliest problem for dairy farmers all over the world. According to Food and Agriculture Organization of the United Nations Report "Impact of Mastitis in Small Scale Dairy Production Systems," annual loss due to Mastitis is 2 Billion USD in the US, 1.5 billion USD in Europe and 2.2 billion USD in India. According to "University of Illinois Extension – Illini DairyNet" and "Foundation Agricounsel Research Study – U.S. Dairy Mastitis Market," Mastitis reduces milk production in the US by 11% and in India by 21%. Mastitis causes 70% of all avoidable losses during milk production. According to an article published in "A Summary of the Reasons Why Farmers Cull Cows" journalofdairyscience.org, Mastitis is ranked second after infertility as the main reason for culling (slaughtering) cows. 20-50% of dairy cows treated for Mastitis in Europe and the USA.

Dr. Siva, Chief Technology Officer of Ariviya, in Chennai Demo Day at IITM Research Park said: “Good udder hygiene practices should be an important part of the daily milking routine. “MammaryO” an udder care product, more specifically a post-dip solution, which would minimize the bacterial infection through our newly invented Nano-Bio polymer technology, it last long in the cow teat until next milking, easily washable, biodegradable and eco-friendly.”

"Preventing Mastitis means, doing big business for dairy farm owners because mastitis affected cow gives less milk, that means they are losing the quantity, and that milk is going to have less fat, that means they are losing the quality, no dairy farm owners want to lose quantity and quality at the same time," said Swami.

“We are actively working with dairy farm owners, Veterinarians, Partners, and Investors across India and United States. They see the value in what we are doing, the deep technology behind our product, the market size, and its demand and shows interest in joining us to scale our product to the next level," said Swami after visiting several dairy farms and its owners in Southern California, USA. According to the article "Top Milk Producing Countries In The World" by worldatlas.com, USA and India are the top 2 milk producing countries in the world respectively, Ariviya presence in these two countries gives an added advantage to meet their vision "Increase milk quality and quantity for Farmers."

About Ariviya Inc
Arivya is inventing Nanobiotechnology solutions for problems in human wellness, animal wellness, agriculture, infrastructures, for example, Bovine Mastitis, Wound healing, Seed protection, Second-degree burn, Water purification. At Ariviya we apply Lean methodology and Deep Technologies in technical research, product development, and commercialization.

Arivya is inventing Nanobiotechnology solutions for problems in human wellness, animal wellness, agriculture, infrastructures, for example, Bovine Mastitis, Wound healing, Seed protection, Second-degree burn, Water purification. At Ariviya we apply Lean methodology and Deep Technologies in technical research, product development, and commercialization.

Contact Details
Ariviya Inc
3060 Coronado Dr, Santa Clara, CA, 95054, USA,
80/73 Chinnaiya St, Pattukkottai, Thanjavur, Tamil Nadu, India, 614602

Email: Press@Ariviya.com
Contact Person Name: Swami Nathan / Ponmani Manimaran
Phone : +1 (650) 704-9343 / +91 63827 81414
www.Ariviya.com
www.facebook.com/AriviyaLabs
www.twitter.com/AriviyaLabs

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release A Deep tech startup is disrupting dairy industry in Chennai Demo Day at IIT-Madras Research Park. here

News-ID: 1594185 • Views:

More Releases from Ariviya Inc.

New business and science behind nanotech biosensors to detect viruses and bacter …
Santa Clara, CA, October 13, 2020, / Press Release/ - New business and science behind nanotech biosensors to detect viruses and bacteria attract deep tech investors and researchers. Ariviya hosted an online event on the new business and science behind nanotech biosensors. Deep tech investors see the unprecedented market opportunity and scientific researchers appreciate the Nanotechnology behind the biosensor. Nano biosensor is a technology that detects viruses and bacteria with high

More Releases for Mastitis

Bovine Mastitis Treatment System Market 2021 In Deep Analysis, Expert Reviews an …
The report studies the Global Bovine Mastitis Treatment System Market with many aspects of the industry like the market size, market status, market trends, and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers. The report offers valuable insight into the Bovine Mastitis Treatment System Market progress and approaches related to the market with an analysis of each region. The
Bovine Mastitis Drugs And Diagnostics Market Size, Growth, Industry Analysis, Op …
The global bovine mastitis drugs & diagnostics market reached a value of nearly $1,508.7 million in 2019, having increased at a compound annual growth rate (CAGR) of 4.5% since 2015. The market is expected to decline from $1,508.7 million in 2019 to $1,322.5 million in 2020 at a rate of -12.3%. The decline is mainly due to lockdown and social distancing norms imposed by various countries and economic slowdown across
Bovine Mastitis Market Growth, Future Prospects And Competitive Analysis to 2027 …
The global bovine mastitis market size is projected to reach USD1.84 billion by the end of 2027. Recent breakthrough concepts will open up the prospect of an exciting future in the global market. According to a report published by Fortune Business Insights, titled “Bovine Mastitis Market Size, Share &COVID-19 Impact Analysis, By Type (Clinical, and Sub-Clinical), By Product (Antibiotics, and Others), By Route of Administration (Intra-mammary, and Systemic), By Therapy
Global Mastitis Market Analysis: Top Players, Trends, Statistics, Technological …
Mastitis Market 2020 comprises a detailed survey of the Mastitis Market size, share, trends, extension, consumption, and share, segments, application and Forecast 2025. Global "Mastitis" Market 2020-2025 Report contains all demographic as well as analytical data regarding market review, growth, demand, and budget analysis. The report mainly highlights the significant trends of the Mastitis market in terms of thriving companies, business methods, product values and pricing, revenue, and sales. With the
Global Mastitis Detectors Market: Size,Share,Analysis,Regional Outlook and Forec …
Global Info Research offers a latest published report on Mastitis Detectors Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Mastitis Detectors players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/global-and-China-Mastitis-Detectors-market_p257434.html Market
Mastitis Market 2019 Share Analysis with Pfizer, Novartis AG, Sanofi S.A., Astra …
The Global Mastitis Market is expected to reach over 18,338 Million USD by 2023, growing at approximately 15.07% CAGR during the forecast period (2017-2023). In the year 2017, the market had valued at USD 7,898.05 Million. Mastitis Market - Key Players Some of key the players in the market are Pfizer (U.S.), Novartis AG (Switzerland), Oncogenex (U.S.), Apthera Inc (U.K), BioNumerik Pharmaceuticals (U.S.), Oncothyreon Inc (US), Astellas (Japan), Bipar Sciences (U.S.), Puma